For example, Jegatheesan et al. [24] reported that the administration of 1 g/kg/d l-CIT in nonalcoholic fatty liver disease (NAFLD) rats reduced TLR4 gene expression. The gene discussed is TLR4; the disease is metabolic dysfunction-associated steatotic liver disease.